Home ›
Organizations ›
FIBROLAMELLAR CANCER FOUNDATION
FIBROLAMELLAR CANCER FOUNDATION
CT · Disease Research · EIN 270341021
4
Executives Disclosed
$3.4M
Annual Revenue
$10.2M
Total Assets
1.6:1
Internal Pay Ratio
FIBROLAMELLAR CANCER FOUNDATION has 4 executives with disclosed compensation. The highest-paid executive, Kurt Losert (CEO), received peak total compensation of $279,981. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Kurt Losert | CEO | $280K | $261K | 2023–2024 | 3.7x |
| John Hopper | DIRECTOR(RETIRED 05/23) | $232K | $92K | 2016–2023 | 3.1x |
| Dr Mark Furth | CHIEF SCIENCE OFFICER | $176K | $172K | 2019–2024 | 2.3x |
| Payal Ray | PROGRAM RESEARCH DIRECTOR | $160K | $160K | 2024–2024 | 2.1x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $176K | $176K | $176K |
| 2017 | 1 | $190K | $190K | $190K |
| 2018 | 1 | $201K | $201K | $201K |
| 2019 | 2 | $175K | $195K | $350K |
| 2020 | 2 | $193K | $222K | $386K |
| 2021 | 2 | $199K | $232K | $398K |
| 2022 | 2 | $204K | $231K | $407K |
| 2023 | 3 | $180K | $280K | $539K |
| 2024 | 3 | $198K | $261K | $593K |
Email Alerts
Get notified about FIBROLAMELLAR CANCER FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.